CD38 and neoplasm: Similar results were observed in B-cell non-Hodgkin lymphoma (B-NHL) cell lines, in primary cells from lymphoma patients, and in lymphoma NOD/SCID mice models, in which CD38-CAR efficiently eradicated tumor cells [89].